2.54

1.60% 0.04

After Hours: 2.54

Treace Medical Concepts Inc (TMCI)

Overview News Price History Option Chain Financials Discussions Forecast

Treace Medical Concepts Inc stock is traded at $2.54, with a volume of 534.82K. It is up +1.60% in the last 24 hours and up +4.96% over the past month. Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Previous Close:

$2.50

Open:

$2.51

24h Volume:

534.82K

Relative Volume:

0.63

Market Cap:

$161.84M

Revenue:

$198.53M

Net Income/Loss:

$-63.68M

P/E Ratio:

-2.4848

EPS:

-1.0222

Net Cash Flow:

$-41.50M

1W Performance:

-2.31%

1M Performance:

+4.96%

6M Performance:

-55.44%

1Y Performance:

-73.81%

1-Day Range:

$2.41

$2.55

1-Week Range:

$2.41

$2.745

52-Week Range:

$2.36

$10.79

Treace Medical Concepts Inc Stock (TMCI) Company Profile

Name

Treace Medical Concepts Inc

Sector

Healthcare (1113)

Industry

Medical Devices (140)

Phone

(904) 373-5940

Address

100 PALMETTO PARK PLACE, PONTE VEDRA

Employee

477

Twitter

Next Earnings Date

2024-11-05

Latest SEC Filings

TMCI's Discussions on Twitter

Compare TMCI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMCI Treace Medical Concepts Inc	2.54	159.30M	198.53M	-63.68M	-41.50M	-1.0222
ABT Abbott Laboratories	108.27	189.14B	44.33B	6.48B	6.92B	3.7033
BSX Boston Scientific Corp	93.61	138.74B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	354.57	136.52B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	100.69	129.06B	34.76B	4.79B	5.21B	3.7017
EW Edwards Lifesciences Corp	83.60	48.90B	5.88B	1.34B	799.60M	2.3489

Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-07-25	Downgrade	BTIG Research	Buy → Neutral
Nov-07-25	Downgrade	JP Morgan	Neutral → Underweight
Feb-04-25	Upgrade	BTIG Research	Neutral → Buy
Dec-31-24	Initiated	Lake Street	Buy
Dec-17-24	Resumed	JP Morgan	Neutral
May-16-24	Downgrade	UBS	Buy → Neutral
May-08-24	Downgrade	BTIG Research	Buy → Neutral
May-08-24	Downgrade	JP Morgan	Overweight → Neutral
May-08-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
May-08-24	Downgrade	Stifel	Buy → Hold
May-08-24	Downgrade	Truist	Buy → Hold
Sep-29-23	Initiated	UBS	Buy
May-01-23	Initiated	Truist	Buy
Apr-11-23	Initiated	Stephens	Equal-Weight
May-12-22	Initiated	BTIG Research	Buy
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
May-18-21	Initiated	JP Morgan	Overweight
May-18-21	Initiated	Morgan Stanley	Equal-Weight
May-18-21	Initiated	SVB Leerink	Outperform
May-18-21	Initiated	Stifel	Buy

View All

Treace Medical Concepts Inc Stock (TMCI) Latest News

Jan 25, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Reach Out - ACCESS Newswire

Jan 25, 2026

Jan 23, 2026